Open to opportunities

Eileen Carry

@eileencarry

Message

I secure biotech funding and turn CNS drug discovery into compelling scientific narratives.

United States

Message

What I'm looking for

I’m seeking opportunities in science writing, grant writing and development consulting, or biotech advisory work where I can translate complex CNS pharmacology into clear scientific, regulatory, investor, and lay-audience narratives.

At Zena Therapeutics, I’ve secured over $1.7M in non-dilutive funding and helped advance CNS drug-discovery programs through NIH/NIDA, NJEDA, and NJDOL awards. I communicate scientific strategy and data to investors, boards, CRO partners, and regulatory consultants while supporting a patented GABA-A receptor modulator platform.

My work spans medicinal chemistry, CNS pharmacology, grant development, peer-reviewed publishing, and commercialization. At Rutgers, I authored 8+ publications, led proposals for GABA-A receptor pharmacotherapies, conducted 100+ customer-discovery interviews through NSF I-Corps and Yale I2I, and helped establish the scientific and IP foundation licensed to Zena Therapeutics.

Experience

Work history, roles, and key accomplishments

Current

Co-Founder & Chief Scientific Officer

Current

Zena Therapeutics, Inc.

Jan 2022 - Present (4 years 7 months)

Authored and secured over $1.7M in non-dilutive funding, including an NIH/NIDA STTR application, NJEDA Catalyst Seed Grant, and NJDOL Innovation Research Fellowship. Led scientific strategy and communication to investors, board members, and partners.

Grant writing Scientific Writing Pharmacology Patent Drafting

Research Associate / Doctoral Researcher

Rutgers University

Jan 2015 - Dec 2023 (8 years 11 months)

Authored 8+ peer-reviewed publications and served as Principal Investigator on NJHF Innovation Awards. Conducted 100+ customer-discovery interviews as Entrepreneurial Lead for NSF I-Corps and Yale I2I.

Medicinal Chemistry Pharmacology Analytical Chemistry Grant writing Customer Discovery Research